Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Smoking history and clinical outcomes in COVID-19 hospitalized patients
Información de la revista
Vol. 159. Núm. 4.
Páginas e27 (Agosto 2022)
Descargar PDF
Más opciones de artículo
Vol. 159. Núm. 4.
Páginas e27 (Agosto 2022)
Letter to the Editor
Acceso a texto completo
Smoking history and clinical outcomes in COVID-19 hospitalized patients
Antecedentes de tabaquismo y resultados clínicos en pacientes hospitalizados por COVID-19
Marco Rossato
Autor para correspondencia

Corresponding author.
, Angelo Di Vincenzo
Clinica Medica 3, Department of Medicine – DIMED, University-Hospital of Padova, Italy
Contenido relaccionado
Med Clin. 2022;159:e2810.1016/j.medcli.2022.03.003
Maria Esther Guisado Espartero, María Sierra Navas Alcántara, Lorena Montero Rivas
Este artículo ha recibido
Información del artículo
Texto completo
Descargar PDF
Texto completo
Dear Editor,

In their paper Navas Alcantara et al. described a large group of patients hospitalized for COVID-19 in Spain focusing on the effects of cigarette smoking history on patients clinical outcomes concluding that an history of cigarette smoking (past or active) is an independent factor for negative prognosis in COVID-19 patients.1

The unhealthy effects of cigarette smoking are well known and have not to be questioned and thus the observations of the Authors are probably expected also in COVID-19 patients. To this respect, at now, it is still debated a possible ‘protective’ effect of active cigarette smoking on the risk of hospitalization for COVID-19 and in particular for interstitial lung pneumonia due to SARS-CoV-2 infection.2–4

These hypothesized protective effect of active smoking on the risk of hospitalization for COVID-19 seems confirmed also by the data reported by the Authors even if they have not highlightened nor discuss them in their paper. Infact as detailed in Table 1 of Navas Alcantara et al. paper, among patients with a history of smoking (previous or active), only 733 were active smokers, i.e. 5% of all considered patients hospitalized for COVID-19.1 This means that among all hospitalized patients for COVID-19 considered by the Authors, 95% were no-active smokers.

Cigarette smoking has to be discouraged for its well known unhealthy effects. Nonetheless, although well far to suggest a ‘protective’ effect of active cigarette smoking on the risk of hospitalization for COVID-19, we have to push research to investigate what are the possible mechanisms leading to this quite low prevalence of active smokers among hospitalized patients for COVID-19 observed also in Spain, a country with about 25% of active smokers.5

M.S. Navas Alcántara, L. Montero Rivas, M.E. Guisado Espartero, M. Rubio-Rivas, B. Ayuso García, F. Moreno Martinez, et al.
Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: results from the SEMI-COVID-19 registry.
Med Clin (Barc), (2021),
S.C. Lee, K.J. Son, D.W. Kim, C.H. Han, Y.J. Choi, S.W. Kim, et al.
Smoking and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Nicotine Tob Res, 23 (2021), pp. 1787-1792
K. Farsalinos, A. Barbouni, R. Niaura.
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?.
Intern Emerg Med, 15 (2020), pp. 845-852
M. Rossato, L. Russo, S. Mazzocut, A. Di Vincenzo, P. Fioretto, R. Vettor.
Current smoking is not associated with COVID-19.
Eur Respir J, 55 (2020), pp. 2001290
Copyright © 2022. Elsevier España, S.L.U.. All rights reserved
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos